# A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery

> **NCT02113150** · PHASE4 · COMPLETED · sponsor: **Turkiye Yuksek Ihtisas Education and Research Hospital** · enrollment: 37 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** remifentanil
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT02113150
- **Lead sponsor:** Turkiye Yuksek Ihtisas Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-09
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02113150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02113150, "A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02113150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*